🇨🇦 Phase 2: Optional ETN, SSZ, HCQ, MTX in Canada

Phase 2: Optional ETN, SSZ, HCQ, MTX (Phase 2: Optional ETN, SSZ, HCQ, MTX) regulatory status in Canada.

Marketing authorisation

Phase 2: Optional ETN, SSZ, HCQ, MTX in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Phase 2: Optional ETN, SSZ, HCQ, MTX approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Phase 2: Optional ETN, SSZ, HCQ, MTX in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.